Publications

Autism

‍

Theoharides drug interactions

Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010

• Autism drug interactions

• Autism mast cells - BBA 2012

• Autism serum IL-6, TNF, luteolin - Transl Psych 9-2015

• Autism subtype brain allergy - Clin Therapeutics May 2013

• Autism, brain inflammation - J Neuroinflammation 2012

• Autism, high serum CRH, neurotensin, dog model - Transl Psych 2104

• Autism, hippocampus, molecular profiling - medRxiv Oct 2022

• Autism, mastocytosis - Intl J Immunopathol Pharmacol 2009

• Autism, NeuroProtek - Clin Therapeutics May 2013

• Autism, NeuroProtek - IJIP6 2012

• Autism, Perinatal stress - BMC Peds 9-2012

• Autism, serum NT

• Mast cells, IL-37 - Intl J Mol Sci 2019

• Molecular Profiling of the Hippocampus of Children with Autism Spectrum Disorder - Abstract - Europe PMC

• Neuroinflammation, seizures, autism - J Neuroinflamm 2011

• Neurotensin, autism - PNAS 2016

• Perinatal mast cells, coronavirus, autism - J Pers Med 2021

• Extracellular vesicles are increased in the serum of children with autism spectrum disorder

• Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders

• Extracellular Mitochondrial ATP, Suramin, and Autism?

• Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6

• Exosomes in Neurologic and Psychiatric Disorders

• Potential Etiologic Factors of Microbiome Disruption in Autism

• Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism

• Mold and Immunity

• Effects of Mycotoxinson Neuropsychiatric Symptoms and Immune Processes

• Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders

• Autism Drugs in Wealthy Nations

• Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders...‍

• Extracellular Mitochondrial Components Secreted from Activated Live Mast Cells Act as “Innate Pathogens” and Contribute to Autism Pathogenesis‍

• The “missing link” in autoimmunity and autism: Extracellular mitochondrial components secreted from activated live mast cells‍

• Focal Brain Inflammation and Autism‍

• NeuroProtek - 2012‍

• Autism, Seizures, JNI 2012‍

• Autism, Allergies JADD‍

• Novel therapeutic targets for autism‍

• Mast cells as targets of corticotropin releasing factor and related peptides‍

• Critical role of mast cells in inflammatory diseases and the effect of acute stress‍

• Autism: an emerging ‘neuroimmune disorder’ in search of therapy‍

• Autism Spectrum Disorders and Mastocytosis‍

• Mercury induces inflammatory mediator release from human mast cells‍

• Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children‍

• Neurotensin is increased in serum of young children with autistic disorder

• Autism, elevated serum CRH, NT-Transl Psych 2014

• Autism, NeuroProtek Clin Therapeutics May 2013

• Autism, NeuroProtek, IJIP6-2012

• Mast cells, stress, fear, autism, Intl J Mol Sci 2019

• Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010

• Atopic conditions, Clin Therapeutics May 2013

• Autism subtype brain allergy Clin Therapeutics May 2013

• Autism, allergies, JADD 2011

‍

Autism Diagnosis & Treatment

‍

• Children with Autism Spectrum Disorders

LEGAL DISCLAIMER:

The contents of this website and any provided materials, research, or communications are for educational and informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.